Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
2005 StandoutScience
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Ketone body metabolism and cardiovascular disease
2013
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
1996
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
1995
Thiazolidinediones
2004 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Expression of Ob Receptor in Normal Human Adrenals: Differential Regulation of Adrenocortical and Adrenomedullary Function by Leptin1
1998
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
1993
Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway
2005
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Mechanism of Metformin Action in Obese and Lean Noninsulin-Dependent Diabetic Subjects*
1991
Cushing's syndrome
2015 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus
1995
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
Glucose and insulin metabolism in cirrhosis
1989
Dietary fibre, lente carbohydrates and the insulin-resistant diseases
2000
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Protein Metabolism in Human Obesity: Relationship with Glucose and Lipid Metabolism and with Visceral Adipose Tissue1
1997
7 Insulin action and substrate competition
1993
Hepatocellular carcinoma
2021 Standout
Expression of a Glucose Transporter Gene Cloned from Brain in Cellular Models of Insulin Resistance: Dexamethasone Decreases Transporter mRNA in Primary Cultured Adipocytes
1989
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
2006
The NAFLD fibrosis score
2007 Standout
Effects of glucocorticoids on carbohydrate metabolism
1988
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
The Effect of Intravenous Metformin on Glucose Metabolism During Hyperglycaemia in Type 2 Diabetes
1992
Non-alcoholic fatty liver disease
2021 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Type 2 diabetes
2017 Standout
Efficacy of Metformin in Type II Diabetes
1997
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
2000
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Leptin and the adrenal gland
2000
Amino Acid and Insulin Signaling via the mTOR/p70 S6 Kinase Pathway
2001
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
2020
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
1999
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
2001 Standout
Adipocyte differentiation from the inside out
2006 Standout
Impact of Weight-Loss Medications on the Cardiovascular System
2007
Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man
1988
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
2015 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
2004
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
NASH and cryptogenic cirrhosis: A histological analysis
2009
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Evidence for a Novel Peripheral Action of Leptin as a Metabolic Signal to the Adrenal Gland: Leptin Inhibits Cortisol Release Directly
1997
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle
1997
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
2002
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease
1990
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
2003
Understanding Adipocyte Differentiation
1998 Standout
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Hyperglycemic Pseudohypoxia and Diabetic Complications
1993
Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes
2002
Assessment of Insulin Sensitivityin Vivo*
1985
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Carbohydrate and Lipid Metabolism in Endogenous Hypercortisolism: Shared Features with Metabolic Syndrome X and NIDDM.
1996
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
2004
Works of Elena Duner being referenced
Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
1986
Effects of chronic alcohol intake on carbohydrate and lipid metabolism in subjects with type ii (non-insulin-dependent) diabetes
1991
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes
2003
No effects of high-fiber diets on metabolic control and insulin-sensitivity in type 1 diabetic subjects
1991
Proinflammatory Cytokines Inhibit Secretion in Rat Bile Duct Epithelium
2001
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients
1992
Metabolic Control of Kidney Hemodynamics in Normal and Insulin-Dependent Diabetic Subjects: Effects of Acetoacetic, Lactic, and Acetic Acids
1987
Type I Diabetes is Characterized by Insulin Resistance Not Only with Regard to Glucose, but also to Lipid and Aminoacid Metabolism*
1986
Carbohydrate and Lipid Metabolism in Cirrhosis. Evidence that Hepatic Uptake of Gluconeogenic Precursors and of Free Fatty Acids Depends on Effective Hepatic Flow*
1984
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects
1983
Insulin Sensitivity, Binding, and Kinetics in Pancreatogenic and Type I Diabetes
1982
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man
1985
Effect of Metformin on Insulin-Stimulated Glucose Turnover and Insulin Binding to Receptors in Type II Diabetes
1987
Acetoacetate and 3-hydroxybutyrate kinetics in obese and insulin-dependent diabetic humans
1985
Glibenclamide induces ductal secretion stimulating vesicular transport in cholangiocytes
2002
Insulin Resistance in Cushing’s Syndrome*
1983